Table 1.
Case summary. Scoring was performed on tissue taken from primary tumors (PT) as well as metastatic lymph nodes (LN).
| Case# | Age/gender | Site of origin | Initial biopsy type | Biopsy CPS | Excision type | Excision CPS |
|---|---|---|---|---|---|---|
| 1 | 80/F | Oral tongue | Cell block (LN) | 20 | Excisional bx (PT) | 30 |
| 2 | 80/F | Unknown primary | Cell block (LN) | 100 | Resection (LN) | 30 |
| 3 | 49/M | Oropharynx, p16+ | Cell block (LN) | 0 | Excisional bx (PT) | 3 |
| 4 | 45/M | Oropharynx, p16+ | Cell block (LN) | 0 | Excisional bx (PT) | 10 |
| 5 | 41/F | Oral tongue | Cell block (LN) | 10 | Excisional bx (PT) | < 1 |
| 6 | 72/F | Hypopharynx | Cell block (LN) | < 1 | Resection (LN) | 2 |
| 7 | 70/F | Unknown primary | Cell block (LN) | 5 | Resection (LN) | 12 |
| 8 | 54/M | Oropharynx, p16+ | Cell block (LN) | 5 | Excisional bx (PT) | 7 |
| 9 | 49/M | Oropharynx, p16+ | Cell block (LN) | 0 | Excisional bx (PT) | < 1 |
| 10 | 53/M | Oropharynx, p16+ | Core biopsy (LN) | 15 | Resection (PT) | 5 |
| 11 | 61/M | Oropharynx, p16+ | Core biopsy (LN) | 2 | Resection (LN) | 15 |
| 12 | 87/M | Unknown primary | Core biopsy (LN) | 0 | Resection (LN) | 0 |
| 13 | 62/M | Pyriform sinus | Core biopsy (LN) | 2 | Excisional bx (PT) | 35 |
| 14 | 78/M | Unknown primary | Core biopsy (LN) | 40 | Resection (LN) | 75 |
| 15 | 47/F | Oropharynx, p16+ | Core biopsy (LN) | 7 | Resection (LN) | 5 |
| 16 | 44/M | Oropharynx, p16+ | Core biopsy (LN) | <1 | Resection (PT) | 5 |
| 17 | 36/M | Oropharynx, p16- | Core biopsy (LN) | 15 | Excisional bx (PT) | 25 |
| 18 | 70/M | Oral tongue | Core biopsy (LN) | 1 | Resection (LN) | 7 |
| 19 | 75/M | Unknown primary | Core biopsy (LN) | < 1 | Resection (LN) | 1 |
| 20 | 53/M | Oropharynx, p16+ | Cell block (LN) | 50 | Resection (PT) | 40 |